[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP3084277B1 - Pig reproductive and respiratory disorder treatment drug - Google Patents

Pig reproductive and respiratory disorder treatment drug

Info

Publication number
JP3084277B1
JP3084277B1 JP11062826A JP6282699A JP3084277B1 JP 3084277 B1 JP3084277 B1 JP 3084277B1 JP 11062826 A JP11062826 A JP 11062826A JP 6282699 A JP6282699 A JP 6282699A JP 3084277 B1 JP3084277 B1 JP 3084277B1
Authority
JP
Japan
Prior art keywords
solution
brilliant blue
blue fcf
drug
prrs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP11062826A
Other languages
Japanese (ja)
Other versions
JP2000256187A (en
Inventor
雅明 西村
鉄夫 浅井
博 田辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Federation of Agricultural Cooperative Associations
Original Assignee
National Federation of Agricultural Cooperative Associations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Federation of Agricultural Cooperative Associations filed Critical National Federation of Agricultural Cooperative Associations
Priority to JP11062826A priority Critical patent/JP3084277B1/en
Application granted granted Critical
Publication of JP3084277B1 publication Critical patent/JP3084277B1/en
Publication of JP2000256187A publication Critical patent/JP2000256187A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

【要約】 【課題】 PRRSウイルスに基因する豚の繁殖障害や呼吸
器症を予防・治療すること。 【解決手段】 クリスタルバイオレットおよびブリリア
ントブルーFCFの一つ又は両者の溶液を噴霧し吸引させ
る。溶液の濃度は0.005−0.01%が望ましい
[PROBLEMS] To prevent and treat pig reproductive disorders and respiratory diseases caused by PRRS virus. SOLUTION: A solution of one or both of crystal violet and brilliant blue FCF is sprayed and sucked. The concentration of the solution is preferably 0.005-0.01%.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は養豚産業における豚繁殖
・呼吸障害症候群の被害を低減させるための薬剤および
同症候群を予防・治療する方法に関する。更に詳述すれ
ば、本発明はブリリアントブルーFCFを有効成分として
含有する薬剤および同溶液を使用する豚繁殖・呼吸障害
症候群を治療・予防する方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drug for reducing the damage of pig reproductive and respiratory disorders in the pig raising industry and a method for preventing and treating the syndrome. More specifically, the present invention relates to a drug containing brilliant blue FCF as an active ingredient and a method for treating and preventing porcine reproductive and respiratory distress syndrome using the same.

【0002】[0002]

【従来の技術】豚繁殖・呼吸障害症候群(PRRS)は、母
豚の繁殖障害と子豚の呼吸器症を特徴とする疾病であ
る。本症は1987年米国で認められ、1990年には
欧州での発生が確認され、今や全世界に蔓延している。
本症による経済的損失は、流産や死産、哺乳豚及び子豚
の死亡、飼料効率の低下、薬剤費や労賃の増加などによ
り甚大な額に上る。本病は、PRRSウイルスの感染により
発症する。また、感染豚は長期間(数ヶ月)に渡りウイル
スを体内に持ち続け他の豚の感染源になる。一度、農場
にPRRSウイルスが侵入すると、農場内にウイルスが存在
し続け、被害が継続する。
BACKGROUND OF THE INVENTION Pig reproductive and respiratory syndrome (PRRS) is a disease characterized by reproductive disorders in sows and respiratory disorders in piglets. The disease was observed in the United States in 1987, was confirmed in Europe in 1990, and is now widespread worldwide.
The economic loss from this disease is enormous due to miscarriage and stillbirth, the death of suckling and piglets, reduced feed efficiency, and increased drug and labor costs. The disease is caused by PRRS virus infection. In addition, infected pigs carry the virus in the body for a long time (several months) and become a source of infection for other pigs. Once the PRRS virus has entered the farm, the virus will continue to exist on the farm and the damage will continue.

【0003】現在、本症を抑えるためのワクチンが開発
されているが、その効果は十分と言えず、効果的な被害
低減法あるいは予防法は皆無といえる。従来、色素剤を
家畜飼育用に使われたことがある(特公昭58−291
号公報)が、使用の目的が異なっている。さらに、色素
剤を豚の呼吸器病や牛の呼吸器病対策に使われた事例が
あるが、いずれも一般細菌に対する効果が報告されてい
るが、本発明で意図するPRRSウイルスの治療、予防につ
いては何ら示唆する記載はない(臨床獣医、第7巻、第
2号、1989,84)。
[0003] At present, vaccines for suppressing this disease have been developed, but their effects are not sufficient, and it can be said that there is no effective damage reduction method or prevention method. Heretofore, coloring agents have been used for raising livestock (Japanese Patent Publication No. 58-291).
Publication), but the purpose of use is different. In addition, there have been cases where pigments have been used to combat respiratory disease in pigs and respiratory disease in cattle, and all of them have been reported to be effective against general bacteria. There is no suggestion about this (Clinical Veterinary, Vol. 7, No. 2, 1989, 84).

【0004】[0004]

【発明が解決しようとする課題】このように、従来の技
術においては、PRRSの被害を抑える方法がなかった。ま
た色素剤の中には動物に対して発癌性や変異原性が疑わ
れ、安全性が危惧されている(MUTAT. RES. 58(2, 3)26
9, 276(1978))。本発明は継続的に豚群の間で循環して
いるPRRSウイルスの感染環を切り、PRRSの被害を抑制す
る方法を提供することを目的とする。
As described above, in the prior art, there is no method for suppressing the damage of PRRS. In addition, some pigments are suspected to be carcinogenic and mutagenic in animals, and their safety is concerned (MUTAT. RES. 58 (2, 3) 26
9, 276 (1978)). An object of the present invention is to provide a method of cutting off the infection cycle of the PRRS virus continuously circulating between herds and suppressing the damage of PRRS.

【0005】[0005]

【課題を解決するための手段】上記問題点を解決するた
めに、本発明はブリリアントブルーFCFがPRRSウイルス
に対して強い殺ウイルス活性があることを見出し、この
殺ウイルス作用を活用し、PRRSの被害を驚異的に減少さ
せる方法を開発した。本発明で使用するブリリアントブ
ルーFCFは食品添加物に指定され、安全性の点でも有利
である(Fd. Chem. Toxic. 28, 221, 1990)。
Means for Solving the Problems In order to solve the above problems, the present invention has found that brilliant blue FCF has a strong virucidal activity against PRRS virus. A method has been developed to dramatically reduce damage. The brilliant blue FCF used in the present invention is designated as a food additive and is advantageous in terms of safety (Fd. Chem. Toxic. 28, 221, 1990).

【0006】本発明にて使用するPRRS被害を低減する薬
剤は下記の実施例に記載する方法により得ることができ
る。
[0006] The PRRS damage reducing agent used in the present invention can be obtained by the method described in the following Examples.

【0007】実施例1 薬剤の調製法 4%クリスタルバイオレット溶液の調製法: クリスタルバイオレット粉末20gにエタノール80ml
を加え、マグネチックスターラーで30分間攪拌し、完
全に溶解させた。これに精製水416mlを攪拌しながら
30分間で加え、全量を500mlにした4%クリスタル
バイオレット溶液を得た。 4%ブリリアントブルーFCF溶液の調製法: ブリリアントブルーFCF粉末20gにエタノール80mlを
加え、マグネチックスターラーで30分間攪拌し、完全
に溶解させた。これに精製水416mlを攪拌しながら3
0分間加え、全量500mlの4%ブリリアントブルーFCF
溶液を得た。 2%クリスタルバイオレット・2%ブリリアントブル
ーFCF混合溶液の調製法: 上記の4%クリスタルバイオレット溶液を250mlおよ
び4%ブリリアントブルーFCF溶液250mlを混合して作
製した。
Example 1 Preparation method of drug Preparation method of 4% crystal violet solution: 20 g of crystal violet powder and 80 ml of ethanol
Was added, and the mixture was stirred with a magnetic stirrer for 30 minutes to completely dissolve. To this, 416 ml of purified water was added with stirring for 30 minutes to obtain a 4% crystal violet solution having a total volume of 500 ml. Preparation method of 4% brilliant blue FCF solution: Ethanol (80 ml) was added to brilliant blue FCF powder (20 g) and stirred with a magnetic stirrer for 30 minutes to completely dissolve. While stirring 416 ml of purified water, 3
Add 0 minutes, 500 ml of 4% Brilliant Blue FCF
A solution was obtained. Preparation of 2% Crystal Violet / 2% Brilliant Blue FCF Mixed Solution: The above 4% crystal violet solution was prepared by mixing 250 ml of the above 4% brilliant blue FCF solution.

【0008】実施例2 薬剤のPRRSウイルスに対する殺滅作用 4%クリスタルバイオレット溶液および4%ブリリアント
ブルーFCF溶液からそれぞれ0.1,1.0,5.0,
10.0および20.0mcg/mlに調整した。各濃度に調
整した薬剤溶液1mlとPRRSウイルス液1mlを混合し、3
7℃で10分間作用させた。ついで、各濃度の薬剤とウ
イルス混合液を速やかに10倍階段希釈し、PRRSウイル
スに感受性がある細胞(MARC-145細胞に接種し、ウイル
ス価を測定した。その結果、ウイルスを1/100以下に殺滅
させた各薬剤の濃度は、表1に示すように、クリスタル
バイオレットでは1mcg/ml以上、ブリリアントブルーFC
Fでは10mcg/ml以上に含有する濃度であった。
Example 2 Killing action of drugs on PRRS virus From a 4% crystal violet solution and a 4% brilliant blue FCF solution, 0.1, 1.0, 5.0,
Adjusted to 10.0 and 20.0 mcg / ml. 1 ml of the drug solution adjusted to each concentration and 1 ml of the PRRS virus solution were mixed and mixed.
Acted at 7 ° C. for 10 minutes. Next, the drug mixture of each concentration and the virus mixture were immediately and serially diluted 10-fold, and cells susceptible to PRRS virus (MARC-145 cells were inoculated and the virus titer was measured. As shown in Table 1, the concentration of each drug killed in Crystal Violet was 1 mcg / ml or more, and Brilliant Blue FC
F had a concentration of 10 mcg / ml or more.

【表1】 [Table 1]

【0009】実施例3 0.01%ブリリアントブルーFCF溶液の噴霧吸引処理に
よるPRRS被害低減効果を試験した。試験を実施した農場
はPRRS汚染農場であり、特に子豚が呼吸器症状を呈して
多く死亡し被害は甚大であった。本農場においては、PR
RS発症豚を減少させて死亡豚を少なくすることを目的
に、0.01%ブリリアントブルーFCF溶液の噴霧吸引処
理を実施した。4%ブリリアントブルーFCF溶液を農場内
の水道水を用いて400倍希釈して0.01%ブリリアント
ブルーFCF溶液に調整した。この0.01%溶液を噴霧器
により哺乳豚および離乳子豚の頭部を中心に薬剤を噴霧
した。子豚の呼吸により、霧状になった薬剤が子豚の鼻
腔、気管、肺に吸引されるように処理した。薬剤の噴霧
吸引処理は毎日1回実施した。その結果、表4に示すよう
に、無処理群では82頭の哺乳豚の内14頭が死亡し、69頭
の離乳子豚の内7頭が呼吸器症状を呈して死亡した。一
方、薬剤の噴霧吸引処理を実施した群では、65頭の哺乳
豚の内1頭が死亡し、64頭の離乳子豚は死亡ゼロであっ
た。以上のように、PRRSウイルスが原因で死亡する子豚
を、薬剤の噴霧吸引処理することにより死亡率を激減さ
せる効果があった。
Example 3 The PRRS damage reduction effect by spray suction treatment of a 0.01% brilliant blue FCF solution was tested. The farm on which the test was conducted was a PRRS-contaminated farm, and in particular, the piglets exhibited respiratory symptoms and died frequently, causing severe damage. In this farm, PR
For the purpose of reducing the number of pigs with RS and the number of dead pigs, spray suction treatment of a 0.01% brilliant blue FCF solution was performed. The 4% brilliant blue FCF solution was diluted 400-fold with tap water on the farm to prepare a 0.01% brilliant blue FCF solution. The 0.01% solution was sprayed with a sprayer on the heads of suckling pigs and weaned piglets. The treatment was performed so that the nebulized drug was sucked into the nasal cavity, trachea, and lungs of the piglets by the respiration of the piglets. The spray suction treatment of the drug was performed once a day. As a result, as shown in Table 4, 14 out of 82 suckling pigs died in the untreated group, and 7 out of 69 weaned piglets died of respiratory symptoms. On the other hand, one of the 65 suckling pigs died and 64 weaned piglets had no deaths in the group that received the drug spray aspiration treatment. As described above, spraying and sucking a drug on piglets that die due to the PRRS virus has the effect of drastically reducing the mortality.

【表2】 [Table 2]

【0010】実施例4 0.005%クリスタルバイオレット、0.005%ブリ
リアントブルーFCF混合溶液の噴霧吸引処理によるPRRS
被害低減効果試験を実施した農場はPRRS汚染農場で、特
に哺乳豚および離乳子豚が呼吸器症状を呈して死亡する
例が多発し、甚大な被害を受けていた。本農場において
は、PRRS発症豚を減少させ死亡豚を少なくすることを目
的に、0.005%クリスタルバイオレットと0.00
5%ブリリアントブルーFCF混合溶液の噴霧吸引処理を実
施した。4%クリスタルバイオレット溶液と4%ブリリア
ントブルーFCF溶液を等量に混合し、農場内の水道水を
用いて400倍希釈して、0.005%混合溶液を調製し
た。この混合溶液を噴霧器により哺乳豚および離乳子豚
の頭部を中心に薬剤を噴霧した。子豚の呼吸により、霧
状になった薬剤が子豚の鼻腔、気管、肺に吸引されるよ
うに処置した。これらの処置は毎日1回実施した。この
結果、表3に示すように、無処理群では152頭の哺乳豚の
内20頭が死亡し、171頭の離乳子豚の内9頭が呼吸器症状
を呈して死亡した。一方、薬剤の噴霧吸引処理を実施し
た群では、169頭の哺乳豚および135頭の離乳子豚での死
亡は0頭であった。以上のように、PRRSウイルスが原因
で死亡していた子豚を、本薬剤の噴霧吸引処理をするこ
とにより激減する効果があった。
Example 4 PRRS by spraying and suctioning a mixed solution of 0.005% crystal violet and 0.005% brilliant blue FCF
The farm on which the damage reduction effect test was conducted was a PRRS-contaminated farm, and in particular, many cases of suckling pigs and weaned piglets died due to respiratory symptoms, and were severely damaged. In this farm, 0.005% crystal violet and 0.005%
A spray suction treatment of a 5% brilliant blue FCF mixed solution was performed. Equal amounts of a 4% crystal violet solution and a 4% brilliant blue FCF solution were mixed and diluted 400-fold using tap water on a farm to prepare a 0.005% mixed solution. The mixed solution was sprayed with a sprayer on the heads of suckling pigs and weaned piglets. Treatment was performed so that the nebulized drug was inhaled into the nasal cavity, trachea and lungs of the piglets by the piglets breathing. These treatments were performed once daily. As a result, as shown in Table 3, in the untreated group, 20 out of 152 suckling pigs died, and 9 out of 171 weaned piglets died due to respiratory symptoms. On the other hand, there were no deaths in 169 suckling pigs and 135 weaned piglets in the group that received spray aspiration treatment. As described above, the effect of drastically reducing the number of piglets that died due to the PRRS virus by spraying and suctioning this drug was obtained.

【表3】 [Table 3]

【効果】既述したように、本発明の薬剤を豚に噴霧吸引
させる処理法は、PRRSの発症を劇的に抑制し、発症死を
顕著に低減させる効果があった。この結果、莫大な経済
的効果を生むことができる。
[Effect] As described above, the method of spraying and sucking the agent of the present invention into pigs has the effect of dramatically suppressing the occurrence of PRRS and remarkably reducing the onset death. As a result, enormous economic effects can be produced.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 田辺 博 埼玉県上福岡市滝2−2−15 (56)参考文献 特開 昭57−42625(JP,A) 特公 昭58−291(JP,B2) (58)調査した分野(Int.Cl.7,DB名) A61K 31/00 - 31/80 CA(STN) CAPLUS(STN)──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor Hiroshi Tanabe 2-2-15 Taki, Kamifukuoka-shi, Saitama (56) References JP-A-57-42625 (JP, A) JP-A-58-291 (JP, B2) (58) Fields investigated (Int. Cl. 7 , DB name) A61K 31/00-31/80 CA (STN) CAPLUS (STN)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ブリリアントブルーFCFを有効成分とし
て含むことからなる、豚繁殖・呼吸器障害症候群治療お
よび予防用薬剤。
1. A medicament for treating and preventing swine reproductive and respiratory disorders comprising a brilliant blue FCF as an active ingredient.
【請求項2】 ブリリアントブルーFCFを有効成分とし
て含有する溶液を畜舎あるいは対象家畜に噴霧し、該溶
液を十分に吸引させることからなる、豚繁殖・呼吸障害
症候群の治療あるいは予防方法。
2. A method for treating or preventing swine reproductive and respiratory distress syndrome, comprising spraying a solution containing brilliant blue FCF as an active ingredient onto a livestock barn or a target animal, and sufficiently inhaling the solution.
【請求項3】 0.005-0.01%濃度の溶液を噴霧
する、請求項2記載の方法。
3. The method according to claim 2, wherein a solution having a concentration of 0.005-0.01% is sprayed.
JP11062826A 1999-03-10 1999-03-10 Pig reproductive and respiratory disorder treatment drug Expired - Fee Related JP3084277B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11062826A JP3084277B1 (en) 1999-03-10 1999-03-10 Pig reproductive and respiratory disorder treatment drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11062826A JP3084277B1 (en) 1999-03-10 1999-03-10 Pig reproductive and respiratory disorder treatment drug

Publications (2)

Publication Number Publication Date
JP3084277B1 true JP3084277B1 (en) 2000-09-04
JP2000256187A JP2000256187A (en) 2000-09-19

Family

ID=13211532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11062826A Expired - Fee Related JP3084277B1 (en) 1999-03-10 1999-03-10 Pig reproductive and respiratory disorder treatment drug

Country Status (1)

Country Link
JP (1) JP3084277B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006188499A (en) * 2004-12-10 2006-07-20 Zaimei Nagayama Virus-removing agent or fungus-removing agent

Also Published As

Publication number Publication date
JP2000256187A (en) 2000-09-19

Similar Documents

Publication Publication Date Title
KR20070092095A (en) Disinfecting composition and methods of making and using same
CN110882215A (en) Safe broad-spectrum povidone iodine preparation and preparation method and application thereof
CN104800167A (en) Florfenicol soluble powder and preparation method thereof
CA2515262A1 (en) Treatment of bacterial diseases of the respiratory organs
JP3084277B1 (en) Pig reproductive and respiratory disorder treatment drug
US12083167B2 (en) Ovotransferrin treatment for the reproductive tract
CN111588698B (en) Florfenicol powder for improving water solubility and preparation method and application thereof
JPH10509463A (en) Methods of treating mammalian diseases caused by an inflammatory response and compositions thereof
CA2425319A1 (en) Treatment and prophylaxis of diseases and infections of pigs and poultry
US20030039703A1 (en) Use of chlorate ion or preparations thereof for reduction of food borne pathogens
US6777448B2 (en) Veterinary compositions for the treatment of parasitic diseases
WO2003051281A2 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
EP3976018B1 (en) Composition for use in the treatment of foot and mouth disease (fmd), scabby mouth (orf), picornavirus, parapoxvirus, and a pathogenic disease causing pox lesions
AU2001235489A1 (en) Veterinary compositions for the treatment of parasitic diseases
JP2637703B2 (en) Method for treating / preventing respiratory disease in swine and therapeutic agent
EP3599855B1 (en) Delayed release feed-through veterinary compositions with ovicidal and larvicidal activity against susceptible and resistant strains of parasites in ruminants' feces, use of these compositions, method for delaying the release of these compositions
CN109432106B (en) Compound sulfachlorpyridazine and preparation method thereof
JP2001081034A (en) Antiprotozoal agent for animal
CN109985022B (en) Povidone iodine preparation and its preparing method and use
CN112336706A (en) Veterinary amitraz solution synergist and preparation method thereof
CN111374964A (en) Bacteriostatic agent for pets and preparation method thereof
RU2097030C1 (en) Preparation for aerosol use for control over respiratory illnesses in animals and birds
CN115715763B (en) Bromhexine hydrochloride solid microsphere and preparation method thereof
CN111150724B (en) Application of valine in preparation of medicine for treating or preventing avian influenza virus infection
RU2179446C1 (en) Preparation to treat and prevent respiratory diseases in youngsters of farm animals

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20000620

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees